awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37883723-B5BE3089-4931-4A50-A3E8-F4B1C28B37CE
Q37883723-B5BE3089-4931-4A50-A3E8-F4B1C28B37CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37883723-B5BE3089-4931-4A50-A3E8-F4B1C28B37CE
Utility of mTOR inhibition in hematologic malignancies.
P2860
Q37883723-B5BE3089-4931-4A50-A3E8-F4B1C28B37CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37883723-B5BE3089-4931-4A50-A3E8-F4B1C28B37CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c16b96d7bea745594f17263b8d2e45516e922c6c
P2860
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia